Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesinurad + Allopurinol in Gout (CLEAR 2)
NCT01493531Phase 3Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Dec 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of lesinurad in gout, sponsored by Ardea Biosciences, Inc.. Started Dec 2011; status: completed.
02
Drugs
lesinurad
03
Conditions
gout
Beyond the preview
Go deeper on NCT01493531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493531.